Q32 Bio (QTTB) FCF Margin Growth (1y) (2019 - 2023)
Q32 Bio (QTTB) FCF Margin Growth (1y) (2019 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 869.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 811.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 769.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 19,111.00 |
| 10 | Q32 Bio | 359.61 Mn | 253.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 418,039.00 |
| Sep 30, 2023 | 396,477.00 |
| Jun 30, 2023 | 364,163.00 |
| Mar 31, 2023 | 341,005.00 |
| Dec 31, 2022 | 69,626.00 |
| Sep 30, 2022 | -168,789.00 |
| Jun 30, 2022 | -283,915.00 |
| Mar 31, 2022 | -373,027.00 |
| Dec 31, 2021 | -296,174.00 |
| Sep 30, 2021 | 378,723.00 |
| Jun 30, 2021 | 342,474.00 |
| Mar 31, 2021 | 463,831.00 |
| Dec 31, 2020 | 730,706.00 |
| Sep 30, 2020 | -299,090.00 |
| Jun 30, 2020 | 377,978.00 |
| Mar 31, 2020 | 383,090.00 |
| Dec 31, 2019 | -646,529.00 |
| Sep 30, 2019 | -103,321.00 |
| Jun 30, 2019 | -736,580.00 |
| Mar 31, 2019 | -759,162.00 |